-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Maintains Neutral on Tandem Diabetes Care, Raises Price Target to $22

Benzinga·02/20/2026 16:48:54
Listen to the news
Mizuho analyst Anthony Petrone maintains Tandem Diabetes Care (NASDAQ:TNDM) with a Neutral and raises the price target from $21 to $22.